TrialBJA open2025

Targeted heart rate control using the funny current inhibitor ivabradine to reduce morbidity in patients undergoing noncardiac surgery: study protocol for a phase 2a, triple-blind, placebo-controlled randomised trial.

Bernardo Bollen Pinto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.